Harmonization of molecular monitoring of CML therapy in Europe.

JJM van Dongen, EA Macintyre, JA Gabert, E Delabesse, V Rossi, G Saglio, E Gottardi, A Rambaldi, G Dotti, F Griesinger, A Parreira, P Gameiro, M González Diáz, M Malec, AW Langerak, JF San Miguel, A Biondi, Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia. ,vol. 13, pp. 1901- 1928 ,(1999) , 10.1038/SJ.LEU.2401592

Susan Branford, Linda Fletcher, Nicholas C. P. Cross, Martin C. Müller, Andreas Hochhaus, Dong-Wook Kim, Jerald P. Radich, Giuseppe Saglio, Fabrizio Pane, Suzanne Kamel-Reid, Y. Lynn Wang, Richard D. Press, Kevin Lynch, Zbigniew Rudzki, John M. Goldman, Timothy Hughes, Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials Blood. ,vol. 112, pp. 3330- 3338 ,(2008) , 10.1182/BLOOD-2008-04-150680

Timothy P. Hughes, Susan Branford, Deborah L. White, John Reynolds, Rachel Koelmeyer, John F. Seymour, Kerry Taylor, Chris Arthur, Anthony Schwarer, James Morton, Julian Cooney, Michael F. Leahy, Philip Rowlings, John Catalano, Mark Hertzberg, Robin Filshie, Anthony K. Mills, Keith Fay, Simon Durrant, Henry Januszewicz, David Joske, Craig Underhill, Scott Dunkley, Kevin Lynch, Andrew Grigg, Impact of early dose intensity on cytogenetic and molecular responses in chronic- phase CML patients receiving 600 mg/day of imatinib as initial therapy Blood. ,vol. 112, pp. 3965- 3973 ,(2008) , 10.1182/BLOOD-2008-06-161737

M Emig, S Saußele, H Wittor, A Weißer, A Reiter, A Willer, U Berger, R Hehlmann, NCP Cross, A Hochhaus, Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR. Leukemia. ,vol. 13, pp. 1825- 1832 ,(1999) , 10.1038/SJ.LEU.2401566

J. Martin Bland, DouglasG. Altman, Statistical methods for assessing agreement between two methods of clinical measurement. The Lancet. ,vol. 327, pp. 307- 310 ,(1986) , 10.1016/S0140-6736(86)90837-8

Brian J. Druker, Shu Tamura, Elisabeth Buchdunger, Sayuri Ohno, Gerald M. Segal, Shane Fanning, Jürg Zimmermann, Nicholas B. Lydon, Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nature Medicine. ,vol. 2, pp. 561- 566 ,(1996) , 10.1038/NM0596-561

J Gabert, E Beillard, V H J van der Velden, W Bi, D Grimwade, N Pallisgaard, G Barbany, G Cazzaniga, J M Cayuela, H Cavé, F Pane, J L E Aerts, D De Micheli, X Thirion, V Pradel, M González, S Viehmann, M Malec, G Saglio, J J M van Dongen, Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program Leukemia. ,vol. 17, pp. 2318- 2357 ,(2003) , 10.1038/SJ.LEU.2403135

G. Daley, R. Van Etten, D Baltimore, Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome Science. ,vol. 247, pp. 824- 830 ,(1990) , 10.1126/SCIENCE.2406902

Tim P. Hughes, Jaspal Kaeda, Susan Branford, Zbigniew Rudzki, Andreas Hochhaus, Martee L. Hensley, Insa Gathmann, Ann E. Bolton, Iris C. van Hoomissen, John M. Goldman, Jerald P. Radich, Frequency of Major Molecular Responses to Imatinib or Interferon Alfa plus Cytarabine in Newly Diagnosed Chronic Myeloid Leukemia New England Journal of Medicine. ,vol. 349, pp. 1423- 1432 ,(2003) , 10.1056/NEJMOA030513

MC Müller, P Erben, Giuseppe Saglio, E Gottardi, Charlotte Guldborg Nyvold, T Schenk, T Ernst, S Lauber, J Kruth, R Hehlmann, A Hochhaus, None, Harmonization of BCR-ABL mRNA quantification using a uniform multifunctional control plasmid in 37 international laboratories. Leukemia. ,vol. 22, pp. 96- 102 ,(2008) , 10.1038/SJ.LEU.2404983